Literature DB >> 8592328

Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).

D de Silva1, F Gilbert, G Needham, H Deans, P Turnpenny, N Haites.   

Abstract

Breast cancer is a multifactorial disease with an inherited predisposition being implicated in around 5% of all cases. Using previous epidemiological data assessing risks for the relatives of women with breast cancer, we have identified 154 women (from a screened population of 35,505) and 289 of their relatives between 50 and 64 years who have more than twice the age related risk of developing breast cancer. This constitutes 1.24% of the breast screening population attending the North East Scotland NHSBSP. For each woman identified to be at high risk, we have found 1.87 female relatives between 50 and 64 years and 1.85 relatives under 50 years also to be at high risk. Around 78% of the women identified with a significant family history of breast or other cancer have attended for counselling about their risks. The breast screening programme can be used to identify women at high risk of breast cancer in order to offer them (and their relatives) access to genetic counselling and appropriate screening.

Entities:  

Mesh:

Year:  1995        PMID: 8592328      PMCID: PMC1051736          DOI: 10.1136/jmg.32.11.862

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  Risk perception, family history, and use of breast cancer screening tests.

Authors:  A P Polednak; D S Lane; M A Burg
Journal:  Cancer Detect Prev       Date:  1991

2.  The association of age and familial risk in a case-control study of breast cancer.

Authors:  C Mettlin; I Croghan; N Natarajan; W Lane
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

3.  Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease.

Authors:  P Margaritte; C Bonaiti-Pellie; M C King; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  Age at onset as an indicator of familial risk of breast cancer.

Authors:  E B Claus; N J Risch; W D Thompson
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

5.  Firmer evidence on the value of breast screening--the Swedish overview.

Authors:  J Chamberlain
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Family history and risk of breast cancer.

Authors:  R S Houlston; E McCarter; S Parbhoo; J H Scurr; J Slack
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

7.  Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.

Authors:  R C Go; M C King; J Bailey-Wilson; R C Elston; H T Lynch
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

8.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

9.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Perception of risk in women with a family history of breast cancer.

Authors:  D G Evans; L D Burnell; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  1 in total

1.  Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.

Authors:  Edenir I Palmero; Maira Caleffi; Lavínia Schüler-Faccini; Fernanda L Roth; Luciane Kalakun; Cristina Brinkmann Oliveira Netto; Giovana Skonieski; Juliana Giacomazzi; Bernadete Weber; Roberto Giugliani; Suzi A Camey; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.